Secondaries Investor LogoPEI Secondaries Investor
News & Analysis

ICG writes €500m cheque for medical single-asset deal

ICG underwrote nearly half the transaction on Curium Pharma, an asset described as 'cream of the crop' by one secondaries buyer.

ByRod James
2 December 2020•2 mins read

Related articles

alt

Swiss LP adviser InPact enters infra secondaries, eyes PE GP-leds

26 August 2026 · 3 mins read

alt

QIC targets shorter plays amid PE’s liquidity crunch

26 August 2026 · 3 mins read

alt

CIP bolsters its liquidity capabilities, hiring head of capital solutions

25 August 2026 · 2 mins read

alt

Secondaries’ emerging leaders: GP-leds to become a proactive portfolio management tool

24 August 2026 · 2 mins read

alt

CV pricing strengthens amid growing buyer competition

21 August 2026 · 3 mins read

alt

Korean LPs embrace PE secondaries, mid-market amid credit controversy

20 August 2026 · 5 mins read

alt

Behind the $400m CFO formed by Churchill and Temasek’s Seviora

20 August 2026 · 5 mins read

motif
Read more